Target intelligence / Profile preview

UDP glucuronosyltransferase 2 family pseudogene

Molecular classification: Other (Pseudogene)

Overview

This target designates a human pseudogene that shares sequence similarity with functional UDP glucuronosyltransferase 2 family proteins. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they typically arise from gene duplication or retrotransposition events. UDP glucuronosyltransferase 2 enzymes (UGT2) are important for glucuronidation, a key phase II metabolism pathway for detoxification and excretion of endogenous and xenobiotic substances, but a pseudogene in this family does not contribute to protein function or metabolism. There is no therapeutic, biological, or disease role attributed to this pseudogene[3][4].

Other names: UDP glucuronosyltransferase family 2 pseudogeneUGT2 pseudogeneUGT2B pseudogene

Beyond the preview

Go deeper on UDP glucuronosyltransferase 2 family pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on UDP glucuronosyltransferase 2 family pseudogene.

Explore the full profile